ArticleBreast cancer research and treatment2022

Factors influencing the initiation of adjuvant endocrine therapy in patients with estrogen receptor-positive ductal carcinoma in situ: a single institution experience.

Julia Levy et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.